Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IIITerminatedSep 26, 2018MethylPREDNISolone TabletsFailed Stability Specifications: An out-of-specification result was obtained during 18-month stability testing for assay.Jubilant Cadista Pharmaceuticals, Inc. · D-1205-2018Class IITerminatedSep 26, 2018Lamotrigine Extended-Release TabletsFailed Dissolution Specifications: Out of Specification for Dissolution test (Buffer Stage) at the 5-hour time point during stability testing.Torrent Pharma Inc. · D-1204-2018Class IITerminatedSep 26, 2018Arthritis Pain Relief Homeopathic FormulaCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Beaumont Bio-med, Inc. · D-1199-2018Class IITerminatedSep 26, 2018Colds & Flu Response Homeopathic FormulaCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Beaumont Bio-med, Inc. · D-1198-2018Class IITerminatedSep 26, 2018Allergy & Hay Fever Relief Homeopathic FormulaCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Beaumont Bio-med, Inc. · D-1197-2018Class IITerminatedSep 26, 2018Muscle & Joint Pain Relief Homeopathic FormulaCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Beaumont Bio-med, Inc. · D-1196-2018Class IITerminatedSep 26, 2018Diarrhea Response Homeopathic FormulaCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Beaumont Bio-med, Inc. · D-1195-2018Class IITerminatedSep 26, 2018Sore Throat & Laryngitis Response Homeopathic FormulaCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Beaumont Bio-med, Inc. · D-1194-2018Class IITerminatedSep 26, 2018Sinus Response Homeopathic FormulaCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Beaumont Bio-med, Inc. · D-1193-2018Class IITerminatedSep 26, 2018Skin Irritation & Itch Response Homeopathic FormulaCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Beaumont Bio-med, Inc. · D-1192-2018Class IITerminatedSep 26, 2018Tizanidine HCl TabletsPresence of Foreign Tablets/Capsules: Glimepiride tablet was found in a bottle of Tinzadine Hcl Tablets .Dr. Reddy's Laboratories, Inc. · D-1191-2018Class IITerminatedSep 26, 20180.9% Sodium Chloride Injection USP 50 mL Viaflex container Baxter Healthcare Corporation DeerfieldcGMP DeviationBaxter Healthcare Corporation · D-1190-2018Class ITerminatedSep 26, 2018Norepinephrine 4 mgSubpotent Drug: Product may not have the active ingredient present in the bag.QuVa Pharma, Inc. · D-0003-2019Class ITerminatedSep 19, 2018Hydrochlorothiazide Tablets USPProduct Mix-Up: customer complaint that a sealed bottle labeled as Hydrochlorothiazide Tablets USP 12.5 mg contained only Spironolactone Tablets USP 25 mg.Accord Healthcare, Inc. · D-1206-2018Class ITerminatedSep 19, 2018RespitrolMicrobial Contamination of Non Sterile Products; Products contaminated with microoganisms, including but not limited to Staphylococcus saprophyticus and Burkholderia...Hellolife · D-1203-2018Class ITerminatedSep 19, 2018ThyroveevMicrobial Contamination of Non Sterile Products; Products contaminated with microoganisms, including but not limited to Staphylococcus saprophyticus and Burkholderia...Hellolife · D-1202-2018Class ITerminatedSep 19, 2018NeuroveenMicrobial Contamination of Non Sterile Products; Products contaminated with microoganisms, including but not limited to Staphylococcus saprophyticus and Burkholderia...Hellolife · D-1201-2018Class ITerminatedSep 19, 2018CompulsinMicrobial Contamination of Non Sterile Products; Products contaminated with microoganisms, including but not limited to Staphylococcus saprophyticus and Burkholderia...Hellolife · D-1200-2018Class ITerminatedSep 19, 2018Furosemide 100 mg added to 0.9% Sodium Chloride 100 mL InjectionPresence of Precipitate: Customer complaint for visible precipitate in product believed to be the active ingredient furosemide.SCA Pharmaceuticals, Inc. · D-1189-2018Class IIITerminatedSep 19, 2018Tyvaso Inhalation System Patient a) Starter Kit with TYVASODefective Delivery System: Water ingress through the lower water cup sensor of the device.United Therapeutics Corp. · D-1188-2018Class IIITerminatedSep 19, 2018Diltiazem HCl Extended-Release CapsulesFailed Impurities/Degradation Specifications: Out of specification test results obtained during routine stability testing for related compound.Mylan Pharmaceuticals Inc. · D-1187-2018Class IIITerminatedSep 19, 2018Diltiazem HCl Extended-Release CapsulesFailed Impurities/Degradation Specifications: Out of specification test results obtained during routine stability testing for related compound.Mylan Pharmaceuticals Inc. · D-1186-2018Class IIITerminatedSep 19, 2018Pramipexole dihydrochloride extended release tabletsFailed impurities/degradation specifications: Finished product contain a known product impurity about current specification levels.Par Pharmaceutical, Inc. · D-1185-2018Class IIITerminatedSep 19, 2018Argatroban InjectionFailed Impurities/Degradation Specifications; Out of specification stability testing results at the 18 month time pointPfizer Inc. · D-1184-2018Class IITerminatedSep 12, 2018Ethosuximide CapsulesFailed Impurities/Degradation Specifications: Out of specification (OOS) results for unspecified impurity.Akorn, Inc. · D-1183-2018Class IITerminatedSep 12, 2018AvKARE Valsartan and Hydrochlorothiazide 320 mg/25 mg tabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Avkare Incorporated · D-1177-2018Class IITerminatedSep 12, 2018AvKARE Valsartan and Hydrochlorothiazide 320 mg/12.5 mg tabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Avkare Incorporated · D-1176-2018Class IITerminatedSep 12, 2018AvKARE Valsartan and Hydrochlorothiazide 160 mg/25 mg tabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Avkare Incorporated · D-1175-2018Class IITerminatedSep 12, 2018AvKARE Valsartan and Hydrochlorothiazide 160 mg/12.5 mg tabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Avkare Incorporated · D-1174-2018Class IITerminatedSep 12, 2018AvKARE Valsartan and Hydrochlorothiazide 80 mg/12.5 mg tabletsCGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.Avkare Incorporated · D-1173-2018Class IITerminatedSep 12, 2018Megestrol Acetate Oral SuspensionSupterpotent DrugMckesson Corporation · D-1172-2018Class IIITerminatedSep 5, 2018RocaltrolSubpotency: lower than expected potency result was obtained at the 18 month stability time point.Validus Pharmaceuticals, Inc. · D-1171-2018Class IIITerminatedSep 5, 2018Calcitriol Oral SolutionSubpotency: lower than expected potency result was obtained at the 18 month stability time point.Validus Pharmaceuticals, Inc. · D-1170-2018Class IITerminatedSep 5, 2018Children s Advil Suspension Ibuprofen Oral SuspensionLabeling Error: Not elsewhere classified. product has a dosage cup marked in teaspoons and the instructions on the label are described in milliliters.Pfizer Global Supply · D-1169-2018Class IIITerminatedSep 5, 2018Azelastine HCl Ophthalmic Solution 0.05%Failed Impurities/Degradation Specifications:out-of-specification (OOS) results for Azelastine N-oxideAkorn, Inc. · D-1168-2018Class IITerminatedSep 5, 2018Methyl-Cobalamin injectableLack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.Auro Pharmacies, Inc. · D-1167-2018Class IITerminatedSep 5, 2018Folic Acid injectableLack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.Auro Pharmacies, Inc. · D-1166-2018Class IITerminatedSep 5, 2018Testosterone Enanthate/Cypionate injectableLack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.Auro Pharmacies, Inc. · D-1165-2018Class IITerminatedSep 5, 2018Testosterone Cypionate/Enanthate injectableLack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.Auro Pharmacies, Inc. · D-1164-2018Class IITerminatedSep 5, 2018Testosterone Cypionate/Enanthate injectableLack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.Auro Pharmacies, Inc. · D-1163-2018

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.